Advanced Medicine Resets Your Metabolism.
GLP-1’s were originally developed to help Type-2 diabetics produce more insulin. They were also discovered to help patients lose weight by activating certain receptors throughout the body. Specifically, GLP-1’s affect the hunger centers in the brain, reducing hunger appetite and cravings. They also slow the rate of stomach emptying, which prolongs the feeling of fullness after a meal. The net effect of GLP-1’s is decreased hunger, prolonged fullness, and ultimately, weight loss!
| Drug | FDA Approval | Primary Use | Cost |
|---|---|---|---|
| Mounjaro® (Tirzepatide) - Eli Lilly & Company | FDA Approved | Chronic weight management in adults and adolecents ages 12 and older with a BMI >27 with a risk factor or >30. | Approximately $500 - $1,200 Months supply. Variable Insurance Coverage. |
| Zepbound® | FDA Approved | Chronic weight management in adults and adolecents ages 12 and older with a BMI >27 with a risk factor or >30. | Approximately $349 - $499 Months Supply. Variable Insurance Coverage. |
| Ozempic® (Semaglutide) - Novo Nordisk | FDA Approved | Treat Type 2 Diabetes in adults. Under investigation for chronic weight management. | Approximately $500 - $1,200 Months Supply. Variable Insurance Coverage. |
| Wegovy® (Semaglutide) - Novo Nordisk | FDA Approved | Chronic weight mangement in adults and adolecents ages 12 and older with a BMI >27 with a risk foctor or >30. | Approximately $499 for a Month's Supply. Variable Insurance coverage |
